The leading investigators and rising stars in Psoriasis

Your weekly stakeholder digest, this week with leading experts in Psoriasis. In this post we outline the opinion leaders, rising stars and other key stakeholders as well as investigator and clinical trials trends.

Read more

Field Insights – Why it's a Crucial Source of Information for Pharma Companies

The flow of information between MSLs and healthcare providers used to be mostly one way: from MSLs to HCPs. This dynamic is changing as MSLs are increasingly tasked with gathering insights from the medical community and relaying it back to close critical data gaps inside the company.

Read more

European Grants! Follow the money to increase your marketing and sales efficiency

It is difficult for sales and marketing professionals to know which leads and prospects that are the most likely to buy products and services. Not every single prospect walks around with a sign above their head that tells you they have cash available to invest in your products – until now. Learn how you can use grants data to sell more and sell smarter.

Read more

8 Reasons why Opportunities for Medical Science Liaisons Will Continue to Grow in 2019 and Beyond

The last years have seen a dramatic increase in the numbers of Medical Science Liaison. As the healthcare industry undergoes dramatic changes, the future of this role is bright as well. Find out 8 important reasons why MSLs are here to stay and thrive.

Read more

Opinion leaders, rising stars and trends within Acute Myeloid Leukemia

Your weekly stakeholder digest, this week with leading experts in Acute Myeloid Leukemia. In this post we outline the opinion leaders, rising stars and other key stakeholders as well as investigator and clinical trials trends.

Read more

5 Reasons for Working with Rising Stars and Young HCPs

Established, influential and widely respected HCPs are highly sought after as KOLs, but as of lately, pharmaceutical companies add a different type of KOL to their roster of external experts and their Advisory Boards. These individuals are young, promising HCPs, who bring less experience but a lot of potential to the table: so-called “Rising Stars”.

Read more